Neuroleptic treatment after episode of neuroleptic malignant syndrome.
Windhager
E
E
Leblhuber
F
F
Pühringer
W
W
D014150:Antipsychotic Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D006801:Humans; D008297:Male; D008991:Monitoring, Physiologic; D009459:Neuroleptic Malignant Syndrome / Q000503:physiopathology*; D012559:Schizophrenia / Q000188:drug therapy*
D014150:Antipsychotic Agents